August 31, 2023
- May 4, 2023 - Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional). See RFA-NS-24-011.
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to notify applicants of a correction to the table of page limits and Instructions for Submission of Multi-component Applications for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)". The Table of Page Limits has been revised to show that the Admin Core is required and a maximum of one Admin Core is Allowed. Additionally, the table has been revised to show that there is a maximum of one Clinical Core and Medicinal Chemistry Core allowed. A summary list has also been added to the Instructions for the Submission of Multi-Component Applications. Lastly, the receipt date has been moved to October 3, 2023 and the expiration date has been moved to October 4, 2023 to allow applicants more time to apply. Changes to the notice of funding opportunity (NOFO) are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| September 26, 2023 | September 26, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
Expiration Date: September 27, 2023
Section IV. Application and Submission Information
2. Content and Form of Application Submission
Page Limitations
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
| Component | Component Type for Submission | Page Limit | Required/Optional | Minimum | Maximum |
|---|---|---|---|---|---|
| Overall | Overall | 12 | Required | 1 | 1 |
| Admin Core | Admin Core | 6 | Required | 1 | $multicomponent.maxInstances |
| Medicinal Chemistry | Medicinal Chemistry | 6 | Required | 1 | NA |
| Clinical Core | Clinical Core | 6 | Required | 1 | NA |
| Project | Project | 12 | Required | 2 | NA |
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing a multi-component application.
Modified to Read:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 3, 2023 | October 3, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
Expiration Date: October 4, 2023
IV. Application and Submission Information
2. Content and Form of Application Submission
Page Limitations
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
| Component | Component Type for Submission | Page Limit | Required/Optional | Minimum | Maximum |
|---|---|---|---|---|---|
| Overall | Overall | 12 | Required | 1 | 1 |
| Admin Core | Admin Core | 6 | Required | 1 | 1 |
| Medicinal Chemistry | Medicinal Chemistry | 6 | Required | 1 | 1 |
| Clinical Core | Clinical Core | 6 | Required | 1 | 1 |
| Project | Project | 12 | Required | 2 | NA |
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing a multi-component application.
- Overall: required, maximum of 1
- Administrative (Admin Core): required, maximum of 1
- Medicinal Chemistry: required, maximum of 1
- Clinical Core: required, maximum of 1
- Projects: required, minimum of 2
All other aspects of this NOFO remain unchanged.
Debra Babcock, PhD, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9964
Email: [email protected]
and Human Services (HHS)
